Different roles for 4-integrin/VCAM-1 and 4/fibronectin interactions in allograft rejection

By Stegall M.D.   Elices M.   Pietra W.   Shepard G.   Gup C.   Gill R.G.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 786-786

Elsevier

Access to resources Recommend Favorite

Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients

By Blume C.   Hollenbeck M.   Ivens K.   Heering P.   Hetzel G.R.   Grabensee B.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3161-3163

Elsevier

Access to resources Recommend Favorite

Chronic kidney allograft rejection is accompanied by increased urinary excretion of fibronectin

By Paczek L.   Pazik J.   Bartlomiejczyk I.   Gradowska L.   Lao M.   Rowinski W.   Szmidt J.   Heidland A.  

Transplantation Proceedings, Vol. 32, Iss. 6, 2000-09 ,pp. : 1333-1334

Elsevier

Access to resources Recommend Favorite

The Cost of Rejection in Liver Allograft Recipients

By Martin J.E.   Fleck P.   Schroeder T.J.   Whiting J.F.   Hanto D.W.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1500-1501

Elsevier

Access to resources Recommend Favorite

Rapamycin and Cyclosporine A Treatment: A Novel Regimen to Prevent Chronic Allograft Rejection in Sensitized Hosts

By Wasowska B.   Hancock W.W.   Onodera K.   Korom S.   Stadlbauer T.H.W.   Zheng X.X.   Strom T.B.   Kupiec-Weglinski J.W.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 333-333

Elsevier

Access to resources Recommend Favorite